New hope for blood cancer patients: experimental drug enters major trial

NCT ID NCT07255872

Summary

This study is testing a new drug, BL-M11D1, in combination with two different sets of standard chemotherapy drugs for adults newly diagnosed with acute myeloid leukemia (AML). The main goals are to find a safe and effective dose and to see how well the combinations work to control the cancer. It will involve about 216 participants across multiple medical centers.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences

    Tianjin, Tianjin Municipality, China

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.